Plasma levels of CA 125 were determined in 113 patients with ovarian cancer of epithelial
origin. Of these, 69 patients had CA 125 measured before the first laparotomy and 84.6% of …

The value of CA 125 measurement in the diagnosis and follow–up of ovarian cancer was
studied in 102 patients. The CA 125 levels were elevated in 88%(3221365) of samples from …

Pre‐operative serum CA 125 levels were elevated (> 35U/ml) in 44 of 46 (96%) patients with
epithelial ovarian cancer. Their serum CA 125 levels ranged from 36 to 8670 U/ml and a …

The serum tumour marker CA 125 is useful in the management of ovarian cancer, although it
has its limitations. Approximately 85% of the ovarian cancer patients have an increased …

In a prospective study of 52 patients with ovarian malignancy followed up for 3–18 months
the clinical significance of pre‐operative serum CA 125 as a tumour marker was assessed …

Serum levels of CA 125 were determined in 239 patients suffering from gynecological
malignancies. The upper limit for normal was 35 U/ml. Raised levels were found in 82% of …

Serum CA 125 levels were evaluated in 227 patients with ovarian cancer. CA 125 levels
were elevated in 86% of the patients. All histologic types, including mucinous tumors, were …

In a single fortuitous case it has been possible to measure serum levels of CA 125 during 3
years preceding the diagnosis of an epithelial ovarian carcinoma. CA 125 levels were …

To determine the potential efficacy of the CA 125 assay as one component of a strategy for
early detection of ovarian malignancy, serum CA 125 levels were determined in 1082 …

Preoperative serum CA 125 levels were determined for 36 patients with Stage I and II
ovarian carcinoma. Levels ranged from 9 to 1962 U/ml with a mean of 216 U/ml. In Stage I …